The cellular response to drug combinations of breast cancer cell lines.

Abstract

<p>(A) MDA-MB-231, (B) MDA-MB-436, (C) BT20 and (D) HCC1143 breast cancer cells were treated with drugs for 24 h and signaling pathway usage was measured by protein phosphorylation of AKT, p70S6K, rpS6, 4E-BP1 and ERK in the four cell lines. Immunoblots with antibodies specific for phosphorylated proteins are indicated. Actin is the loading control.</p